| Effects of hypertension and obesity on the sympathetic activation of heart failure patients. | |
| | |
MedLine Citation:
|
PMID: 14568999 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Previous studies have shown that congestive heart failure is characterized by sympathetic and reflex dysfunctions. Whether these alterations are potentiated in the presence of obesity and hypertension, two conditions that also display neuroadrenergic abnormalities and markedly increase the risk of heart failure, is unknown. In 14 healthy control subjects (C; age, 55.1+/-3.0 years; mean+/-SEM), 13 lean hypertensive subjects (H), 15 obese normotensive subjects (O), 14 lean normotensive subjects with congestive heart failure (CHF, New York Heart Association class II), 14 lean hypertensive subjects with CHF (CHFH), 14 obese normotensive subjects with CHF (CHFO), and 13 obese hypertensive subjects with CHF (CHFOH), all age-matched with C, we measured mean blood pressure (Finapres), heart rate (ECG), and muscle sympathetic nerve traffic (MSNA, microneurography) at rest and during baroreflex testing. Compared with C, body mass index was similarly increased in O, CHFO, and CHFOH, whereas mean blood pressure was similarly increased in HF, CHFH, and CHFOH, and left ventricular ejection fraction (echocardiography) was similarly reduced in CHF, CHFH, CHFO and CHFOH. Compared with C, MSNA was significantly increased in O, H, and CHF (43.0+/-2.2 versus 54.1+/-2.8, 53.1+/-2.5, and 57.4+/-2.8 bursts/100 heart beats, P<0.01). When O or H was combined with CHF, the MSNA increase was significantly more pronounced and maximal when O and H were concomitantly associated with CHF. Baroreflex sensitivity was reduced in O and H, with a further reduction in CHF and a minimal value in CHFOH. These data show that the sympathetic activation characterizing CHF is markedly potentiated when O and H alone or combined together are associated with a low cardiac output state and that this may depend on an arterial baroreflex impairment. |
| | |
Authors:
|
Guido Grassi; Gino Seravalle; Fosca Quarti-Trevano; Raffaella Dell'Oro; Gianbattista Bolla; Giuseppe Mancia |
Related Documents
:
|
19901159 - Evidence for sympathetic origins of hypertension in juvenile offspring of obese rats. 10619579 - The effect of weight loss intervention on antihypertensive medication requirements in t... 1985149 - Association between post-dexamethasone cortisol level and blood pressure in depressed i... 2378649 - Airflow limitation in morbidly obese, nonsmoking men. 9449439 - Direct measurement of intra-abdominal pressure in various conditions. 8600609 - Is low birth weight a risk factor for adult hypertension? a literature review with part... 10941789 - Pressure response in deep-sea piezophilic bacteria. 7631859 - Noninvasive measurements of albumin flux into lung interstitium with increased microvas... 19163229 - Comparison of maximum cross-correlation coefficient between blood pressure and heart ra... |
Publication Detail:
|
Type: Journal Article Date: 2003-10-20 |
Journal Detail:
|
Title: Hypertension Volume: 42 ISSN: 1524-4563 ISO Abbreviation: Hypertension Publication Date: 2003 Nov |
Date Detail:
|
Created Date: 2003-11-07 Completed Date: 2003-12-04 Revised Date: 2007-11-15 |
Medline Journal Info:
|
Nlm Unique ID: 7906255 Medline TA: Hypertension Country: United States |
Other Details:
|
Languages: eng Pagination: 873-7 Citation Subset: IM |
Affiliation:
|
Clinica Medica, Dipartimento di Medicina Clinica, Prevenzione e Biotecnologie Sanitarie, Università Milano-Bicocca, Centro Interuniversitario di Fisiologia Clinica e Ipertensione and Istituto Auxologico Italiano, Milan, Italy. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Blood Pressure Heart Failure / diagnosis, etiology*, physiopathology Heart Rate Humans Hypertension / complications*, physiopathology Male Middle Aged Muscles / innervation Norepinephrine / blood Obesity / complications* Pressoreceptors / physiopathology Sympathetic Nervous System / physiopathology* |
| Chemical | |
Reg. No./Substance:
|
51-41-2/Norepinephrine |
| Comments/Corrections | |
Comment In:
|
Hypertension. 2003 Nov;42(5):870-2
[PMID:
14569000
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Chronic administration of adrenomedullin attenuates transition from left ventricular hypertrophy to ...
Next Document: Renal effects of omapatrilat and captopril in salt-loaded, nitric oxide-deficient rats.